ADELAIDE, AUSTRALIA, May 25, 2023 – Carina Biotech (Carina), a cell therapy immuno-oncology company, today announced that the management team will participate in the three upcoming conferences as follows: 9th Annual Immuno-Oncology Innovation Forum
Carina Biotech to Present Details of Planned Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy Candidate CNA3103 for Metastatic Colorectal Cancer at 2023 ASCO Annual Meeting First in human, multicenter,
Carina Biotech to Present Preclinical Data Evaluating LGR5-Targeted CAR-T Cell Therapy in Colorectal Cancer Models at 2023 AACR Preclinical data demonstrates that LGR5-targeting CAR-T therapy has high potential as an
